DJIA 16,027.05 -177.92 -1.10%
NASDAQ 4,283.75 -79.39 -1.82%
S&P 500 1,853.44 -26.61 -1.42%
market minute promo

Regeneron Pharmaceuticals (NASDAQ: REGN)

390.53 -6.08 (-1.53%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $390.53 -1.53%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $380.70
Previous Close $396.61
Daily Range $376.61 - $393.64
52-Week Range $376.61 - $605.93
Market Cap $40.6B
P/E Ratio 78.38
Dividend (Yield) $0.00 (0.0%)
Volume 1,224,550
Average Daily Volume 977,572
Current FY EPS $9.78

Sector

Healthcare

Industry

Drug Makers

Regeneron Pharmaceuticals (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary

Why Ophthotech Corporation Shares Tumbled 31% in January

The launch of trials in dry age-related macular degeneration failed to spark shares last month.

Pre-Market Earnings Report for February 9, 2016 : KO, CVS, REGN, OMC, HCP, FIS, VIAB, IR, AGU, TDG,

Pre-Market Earnings Report for February 9, 2016 : KO, CVS, REGN, OMC, HCP, FIS, VIAB, IR, AGU, TDG, SNY, MAS

All Biotech Is Going Lower - Cramer's Lightning Round (2/5/16)

'Mad Money' Lightning Round: Expect More Pain From Regeneron Pharmaceuticals

Regeneron (REGN) to Report Q4 Earnings: What's in Store?

3 Things to Look for in Regeneron Pharmaceuticals Inc.'s Earnings

From Eylea sales to the late-stage pipeline, here are the three areas this Fool will be watching in Regeneron's fourth-quarter report.

EWT, PTH: Big ETF Outflows

Biotech Stock Roundup: Biogen, Amgen Top Estimates; Zika Virus Grabs Attention

Avalanche (AAVL) Set to Acquire Annapurna Therapeutics

Why Regeneron Pharmaceuticals Shares Fell 23% in January

The broad market sell-off hit biotech stocks hard last month.

See More REGN News...

REGN's Top Competitors

REGN $390.53 (-1.53%)
Current stock: REGN
AMGN $143.00 (-1.41%)
Current stock: AMGN
GILD $85.26 (0.14%)
Current stock: GILD
BIIB $250.77 (-4.96%)
Current stock: BIIB